Telomir Pharmaceuticals, Inc. Common Stock (TELO) — Financial Flexibility Index
Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a Financial Flexibility Index of -2.14x as of March 2026. Free cash flow of $-1.77 Million (operating CF $-1.77 Million minus capex $0.00) represents -2% of total liabilities ($827.31K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Telomir Pharmaceuticals, Inc. Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Telomir Pharmaceuticals, Inc. Common Stock across 5 annual periods. See working capital position of Telomir Pharmaceuticals, Inc. Common Sto to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Telomir Pharmaceuticals, Inc. Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for Telomir Pharmaceuticals, Inc. Common Stock. For the full company profile including market capitalisation, see TELO market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.58x | $-3.69 Million | $-3.69 Million | $1.43 Million | ▲ +65.3% |
| 2024 | -7.45x | $-5.07 Million | $-5.07 Million | $680.97K | ▼ -157.6% |
| 2023 | -2.89x | $-3.86 Million | $-3.86 Million | $1.34 Million | ▼ -508.0% |
| 2022 | -0.48x | $-468.66K | $-468.66K | $986.01K | ▲ +45.0% |
| 2021 | -0.86x | $-119.39K | $-119.40K | $138.13K | — |